Human clinical trial findings, with references to published research.
How to buy research-grade peptides in Thailand with confidence — what to check before you order, what compounds actually cost in baht, how nationwide delivery works, and which peptides are most commonly researched. A practical guide for buyers in Bangkok, Pattaya, Phuket and beyond.
25 July 2026 · 11 min readA Bangkok-specific guide to research peptides — how delivery works across the city's districts, the condo-reception problem nobody warns you about, why Bangkok's heat is the biggest threat to what you buy, and how research compounds differ from what clinics offer.
24 July 2026 · 9 min readThe Phase 2 NEJM trial of retatrutide recorded 24.2% mean weight loss at 48 weeks — the largest reduction ever seen in a Phase 2 peptide trial.
28 May 2026 · 9 min readThe SURMOUNT-1 trial in NEJM 2022 showed tirzepatide 15 mg produced 22.5% mean weight loss in 2,539 participants — more than any previously approved weight-loss drug.
21 May 2026 · 9 min readThe STEP-1 trial in NEJM 2021 established semaglutide 2.4 mg as the first GLP-1 peptide to produce clinically significant weight loss — 14.9% mean reduction in 1,961 participants.
14 May 2026 · 9 min readThree consecutive NEJM trials — STEP-1, SURMOUNT-1, and the retatrutide Phase 2 — enrolled 5,838 subjects and tell a clear story: each generation of GLP-1 peptide meaningfully outperforms the last.
7 May 2026 · 10 min readTesamorelin is the only peptide with FDA approval specifically for visceral fat reduction. The pooled Phase 3 analysis of 806 patients showed a 15.4% reduction in visceral adipose tissue at 26 weeks.
30 April 2026 · 8 min readA Phase I trial in 84 healthy subjects confirmed TB-500's safety and dose-proportional pharmacokinetics. A subsequent cardiac repair trial showed a 67-metre improvement in 6-minute walk distance in acute MI patients.
23 April 2026 · 8 min readA randomised trial in 67 women with moderate facial ageing found that topical GHK-Cu produced collagen increases in 70% of subjects — outperforming tretinoin (40%) over 12 weeks.
16 April 2026 · 8 min readBPC-157 has a compelling animal literature spanning decades. A 2025 human safety pilot (2 subjects) confirmed IV tolerability. Efficacy trials in humans have not yet been published.
9 April 2026 · 8 min readTwo Phase I human trials — Dorr et al. (1996) and Wessells et al. (1998) — confirmed dose-dependent melanogenesis and tanning in human subjects following subcutaneous Melanotan 2 administration.
2 April 2026 · 8 min readResearch peptides are compounds studied in controlled settings to understand their biological effects. This post explains the development pipeline from preclinical research through Phase I, II, and III trials to regulatory approval.
26 March 2026 · 9 min read